CMPH - Initial Marketing Authorisation Applications,Europe, February

... The Committee for Medicinal Products for Human Use (CHMP) adopted positive opinions on initial marketing authorisation applications for:-- Duotrav (travoprost/timolol maleate), Alcon Laboratories. Duotrav is an eye-drops solution, intended for the decrease of intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues... click link for more info. ...